Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-022015
Filing Date
2008-04-02
Accepted
2008-04-02 14:56:32
Documents
5
Period of Report
2008-02-29

Document Format Files

Seq Description Document Type Size
1 10-Q a08-9519_110q.htm 10-Q 1504975
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) a08-9519_1ex31d1.htm EX-31.1 15390
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) a08-9519_1ex31d2.htm EX-31.2 14971
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 a08-9519_1ex32d1.htm EX-32.1 4691
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 a08-9519_1ex32d2.htm EX-32.2 4598
  Complete submission text file 0001104659-08-022015.txt   1546054
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-14820 | Film No.: 08733033
SIC: 2835 In Vitro & In Vivo Diagnostic Substances